SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-125137
Filing Date
2019-04-29
Accepted
2019-04-29 16:05:02
Documents
4
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d736935ddefa14a.htm DEFA14A 32217
2 GRAPHIC g736935g44d88.jpg GRAPHIC 10029
3 GRAPHIC g736935g46n36.jpg GRAPHIC 62171
4 GRAPHIC g736935g51p37.jpg GRAPHIC 63431
  Complete submission text file 0001193125-19-125137.txt   220523
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 19775865
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences